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Summary 
Background. Precise preoperative assessment of diagnosis and prognosis in patients with pancreatic tumors 
would facilitate improvement of treatment s rategies. In this context, we evaluated the signifcance of the pro- 
liferative index and of static DNA cytophotometry in the diagnosis and prognosis of pancreatic tumors. 
Methods. Consecutive surgical specimens from 26 patients with ductai pancreatic ancers and eight 
patients with chronic pancreatitis were investigated by: 
1. Staging: 
2. Conventional histological and cytological grading; 
3. MIB-1 (Ki-67 labeling) proliferating index; and 
4. Static DNA cytophotometry. 
Results. All patients with chronic pancreatitis had a normal MIB-I labeling index and a cuploid DNA 
content, in contrast, patients with pancreatic ancers rarely had a normal abeling index ( I of 26 patients) 
on" a euploid DNA content (6 of 26 patients). Staging significantly correlated with survival time. However, 
it did not correlate with cytological criteria. Cytological criteria, such as conventional grading, MIB-1 pro- 
liferating index, and DNA ploidy, were not significantly correlated with survival time. Conventional grad- 
ing was significantly correlated (p < 0.02) with proliferating index, but not with DNA ploidy. 
Conclusion. Proliferating index and DNA ploidy are relevant cytological markers that can help to 
discriminate between chronic pancreatitis and pancreatic cancer. The prognostic significance of these 
markers in pancreatic cancer patients, however, seems to be less relevant than tumor stage and of lim- 
ited relevance for the individual cancer patient. 
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nostic ~ignificance; survival. 
Introduction 
Despite recent improvements in surgical and mul- 
tidisciplinary treatment, the overall prognosis for 
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patients with ductal pancreatic ancer remains poor 
(I). One important step in the diagnostic workup is 
the accurate preoperative assessment of prognosis 
(2). This would influence the decision of whether 
the tumor should be surgically resected. Thus far, 
tumor, node, and metastases (TNM) staging and 
grade of  differentiation obviously correlated with 
survival (3,4). Even though preoperative imaging 
has substantially facilitated accurate staging, pre- 
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and even postoperative assessment of the biological 
behavior of the tumor still remain difficult. 
Subjective grading can be supplemented by objec- 
tive measurements of proliferative activity. Immuno- 
h istochemical  methods for the detect ion of 
proliferation-related antigens, uch as the Ki-67 anti- 
gen, are in frequent use. Ki-67 is present in cycling 
cells with peak concentrations during the G 2- and 
M-phases of the cell cycle and minimal concentra- 
tions in the G O or early Gl-phase. In this context, it 
is of interest hat the monoclonal antibody (MAb) 
MIB- l is a true equivalent of Ki-67. It can be detected 
in formalin-fixed, paraffin-embedded material (5). 
A number of studies have indicated that the MIB- 1 
proliferation index is of important prognostic sig- 
nif icance for a variety of neoplasms, such as 
esophageal nd renal tumors (6, 7). 
Furthermore, there is a correlation between sur- 
vival and DNA ploidy of cancer cells in most human 
malignant neoplastic diseases (8,9). When the DNA 
ploidy of the neoplastic ells is a so-called aneu- 
ploid type, the malignant disease is usually rather 
aggressive, showing rapid progression. In contrast, 
tumors with a euploid DNA distribution pattern usu- 
ally are less aggressive r garding long-term survival. 
Pancreatic cancer, however, anks among the most 
aggressive of human malignant neoplasms (1). The 
exact value of assessing proliferative activity and 
DNA ploidy in both preoperative cytological spec- 
imens and postoperative surgical specimens of pan- 
creatic cancer is still highly debated and warrants 
further evaluation (10-16). We assessed the prog- 
nostic significance of proliferative activity and DNA 
ploidy of malignant pancreatic cells using postop- 
eratively saved histological sections. 
Materials and Methods 
Subjects 
From 1989 to 1995, 61 consecutive patients admit- 
ted to the Surgical Departement of the Martin-Luther 
University of Halle-Wittenberg for laparotomy 
owing to pancreatic tumors were retrospectively 
enrolled in the study. Twenty-six patients had typi- 
cal ductal adenocarcinomas of the pancreas, and 
eight patients had chronic pancreatitis without 
malignancy. Formalin-fixed, paraffin-embedded sur- 
gical specimens from these 34 patients were exam- 
ined. The following 27 patients were excluded: 
1. Five patients with bile duct cancer; 
2. Five patients with cancers of the ampulla of Vater; 
3. Four patients with insulinoma; 
4. Two patients with osteoclast-like giant cell 
tumors; 
5. One patient with a neuroendocrine cancer; 
6. One patient with a papillary cystic tumor; 
7. Two patients with mucinous cystadenocarci- 
noma; and 
8. Seven patients with liver or lymph node metas- 
tases without issue from the primary tumor. 
Pathologic staging was performed according to the 
criteria of the International Union Against Cancer 
(UICC) TNM staging system (17). 
Followup 
Patients were followed until death, All patients 
had undergone surgery and had their diagnosis of 
ductal pancreatic cancer confirmed by histology. 
Conventional histology 
Histological assessment and cytomorphological 
grading (grades 1-3) were performed on coded his- 
tological sections by one senior pathologist (J. K.) 
as previously described (17). 
MIB-1 Immunohistochemistry 
for Ki-67 Expression 
Ki-67-expressing nuclei were stained and quan- 
tified with slight modifications from previous 
descriptions (7). In brief, deparaffinized tissue sec- 
tions (2.5 Bin) were placed in citrate buffer (pH 6.0) 
and exposed to microwaves 3-6 times for 5 rain at 
600 W and then incubated for 1 h at 37~ with the 
MAb MIB-1 (dilution 1 : 10) (Dianova, Hamburg, 
Germany). Primary antibody was detected by the 
avidin-biotin-peroxidase complex technique using 
a commercially available reagent kit. MIB- I-labeled 
nuclei in lymph follicles were used as positive con- 
trols. Only slides that showed adequate MIB- 1 label- 
ing of nuclei in lymph follicles were used. The 
percentage ofMIB- 1-positive cell nuclei were deter- 
mined by scoring a minimum of 400 cells in the most 
extensively immunostained areas (magnification: 
x400); all positive staining regardless of the inten- 
sity was regarded as positive. The counting was con- 
tinued until the accumulated mean varied by <5%. 
The indices were calculated as the percentage ofpos- 
itively staining tumor cell nuclei of the total number 
of tumor cells counted. 
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DNA Cytophotometry 
DNA cytophotometry was perfi)rmed essentially 
as previously described (7) with slight modifica- 
tions. In brief, paraffin-embedded tissue was cut (8 
btm) and stained according to the Feulgen method. 
Cytometric assessment of the nuclear DNA content 
was performed using an image analysis system on 
"CYDOK"  based on the light microscope 
"'ZYTOPAN'" (C. Reichert AG Wien, Austria). 
Absorption of the probes was determined at a wave- 
length of 560 nm. For each patient, approx 100 nuclei 
were analyzed. The image was analyzed using mor- 
phometric riteria based on the site of the nuclei and 
their gray values, which ensured that both artifacts 
(dirt, duplets, and so forth) and inflammatory cells 
(lymphocytes, and so on) were excluded from the 
analysis. Determination of the diploid values was 
performed with normal ductal epithelial cells (coef- 
ficient of variability: 3.2c,~); the diploid region of 
cellular DNA content was defined as 2c _+ 10%. This 
definition was used to achieve adequate sensitivity 
and high specificity of the technique. DNA data were 
classified into four different histogram types accord- 
ing to Auer et al. (9). 
Statistical methods 
Survival was presented according to the Kaplan- 
Meier method, and the groups were compared with 
the log-rank test. Correlation analysis was perR)rmed 
according to Spearman as described by Sachs (18). 
Results 
Clinical Characteristics, Pathological TNM 
Stage, and Surgical Procedure 
The median age of the patients at resection of the 
primary tumor was 60 yr (range: 40-73 yr). There 
were 12 women and 14 men. Two, 8, 13. and 3 patients 
had a pathological tumor stage I, II, I11. and IV, 
respectively. Two, 14, and 10 patients had a patho- 
logical T-stage T i, T 2, and T 3, respectively. Thirteen 
patients each had a pathological N-stage N o and N 1, 
respectively. Twenty-three and three patients had a 
pathological M-state M 0 and M I, respectively. Stage 
IV with liver metastases was not diagnosed preop- 
eratively, but histologically during surgery (three 
patients had small [<1 cm] liver metastases). These 
patients with small liver metastases received biopsy 
of both the pancreatic tumor and at least one liver 
metastases. The pancreatic tumor was resected in 
patients with stage I-ll l by the Whipple procedure. 
Patients with stage IV were treated by a biliary 
decompression procedure. The tumor was localized 
in 20, 4, and 2 patients in the head, corpus, and cauda 
of the pancreas, respectively. 
Conventional Grading 
Cytomorphological grading showed high (grade I ), 
medium (grade 2), or low (grade 3) differentiation 
in 1, 16, and 9 patients, respectively. 
MIB-I Proliferating Index 
The MIB-I proliferation index was normal (<I %, 
of all epithelial cells) in all patients with chronic 
pancreatitis and in one patient with a highly differ- 
entiated (grade 1) pancreatic ancer. Twelve. four, 
and nine cancer patients had low, medium, and 
high numbers of M1B-l-labeled cells, respectively 
(Table 1, Fig. 1). 
DNA Cytomorphometry 
All patients with chronic pancreatitis had a euploid 
DNA content in the ductal epithelium in contrast o 
only 23% (6 of 26 patients) of pancreatic ancers. 
All conventional grade 3 differentiated tumors had 
cells with a DNA content >9c. DNA histogram clas- 
sification according to Auer et al. was as follows: 
type 1: no patient, type II: 4 patients, type Ill: 4 
patients, and type IV: 18 patients (Table 1, Fig. 2). 
Survival 
TNM stage correlated significantly with survival 
time. The 24-mo survival rate of patients with a stage 
I or li tumor was 35%. In contrast, conventional 
grading, MIB-1 proliferating index, and DNA ploidy 
did not correlate with survival time (Fig. 3). 
Correlation Analysis 
Staging did not significantly correlate with cyto- 
logical criteria. Com,'entional grading was signifi- 
cantly correlated (p < 0.02) with MIB- 1 proliferating 
index, but not with DNA ploidy. DNA ploidy did not 
show a significant correlation with conventional 
grading or MIB-I proliferating index. 
Discussion 
We evaluated the proliferative activity and DNA 
ploidy of epithelial cells in benign and neoplastic 
pancreatic lesions. All patients with chronic pan- 
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Table 1 
Relationship Among MIB- I Proliferating Index, Conventional Grading, DNA Ploidy, 
and Histogram Type of Auer in Patients with Pancreatic Cancer 
MIB-I proliferating index 
Normal Low Medium High 
All cancers (N: 26) 1 12 4 9 
Conventional grading (I 7) 
Grade I (N: I) 1 0 0 0 
Grade 2 (N: 16) 0 l 0 2 4 
Grade 3 (N: 9) 0 2 2 5 
DNA ploidy (defined in Materials and Methods) 
Euploid (N: 6) 0 5 0 1 
Ancuploid IN: 20) I 7 4 8 
Histogram type of Auer et al. (9) 
Type I (N: 0) 0 0 0 0 
Type 2 (N: 4) 0 3 0 I 
Type 3 (N: 4) 0 1 2 I 
Type 4 (N: 18) 1 8 2 7 
. . 9 ' ~ . ~  
Fig. 1. MIB-I immunostaining in a moderately differentiated pancreatic cancer (bar I00 lam). 
creatitis howed a normal MIB-1 proliferating index 
and a euploid DNA content. In contrast, all but one 
patient with pancreatic ancer expressed increased 
M1B- I proliferating indices and only 23% of pan- 
creatic cancer patients had a euploid DNA content. 
Thus, M1B- I proliferating indices and DNA ploidy 
offer help in solving practical diagnostic problems, 
both in cytodiagnostic and histopathological speci- 
mens. It is well known that pathologists can be faced 
with a fine-needle aspiration or surgical biopsy spec- 
imen from a patient with a suspicious lesion in the 
pancreas for which the differential diagnosis is 
chronic pancreatitis or pancreatic ancer. Here, the 
results of a cytometrical DNA analysis can be of 
paramount importance, since the finding of a high 
MIB- 1 index or an aneuploid DNA content strongly 
indicates the existence of pancreatic ancer. This 
may be especially relevant if only minimal amounts 
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Fig. 2. Examples of typical DNA histograms. (A) type 
1: cuploid. (B) type II: euploid, (C) type Ill: aneuphfid, 
(D) type IV: aneuploid. (A) shows the DNA distribution 
pattern of a patient with chronic pancrcalitis. (B-D) show 
the DNA distribution patterns of patients with pancre- 
atic cancer. 
of cytological material are available. Diagnosis of 
pancreatic cancer, however+ should not exclusively 
rely on these parameters, ince these changes may 
rarely also occur in precursor lesions. Furthermore. 
preoperative fine-needle aspiration is debated 
because of the fear of tumor cell dissemination. 
Whenever possible brush cytology from the bile and 
pancreatic duct should be performed uring endo- 
scopic retrograde cho langiopancreatography 
(ERCP), which is not associated with tumor seeding. 
Percutaneous fine-needle aspiration, which has a 
potential risk of tumor seeding, should be restricted 
to patients wilh no or minimal hope for cure by sur- 
gical resection. 
With respect o cancer grading, poorly differen- 
tiated neoplastic ells usually have higher MIB-I 
proliferating indices. For several neoplasms, both 
poor differentiation and high MIB-I proliferating 
indices were reported as being associated with 
reduced survival time (7. t 9.20). In pancreatic cancer, 
high MIB-1 proliferating indices were found to cor- 
relate with short survival time (16). In our study, 
however, the MIB-I proliferating indices did not 
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Fig. 3. Kaplan-Meier curves demonstrating the prob- 
ability of survival of patients with pancreatic cancer. (A) 
Conventional cytological grading. (B) MIB-1 proliferat- 
ing index. (C) DNA ploidy. (D) DNA histogram types, 
(E) pathological tumor stage. 
reveal such correlation with survival time. The vari- 
ation in results between studies may be explaincd 
by differences in the study populations, the tumor 
stage, the surgical procedures, the immunohisto- 
chemical techniques, or the statistical methods. In 
contrast o the cytological markers, our study fully 
confirms previous studies on the prognostic effect 
of tumor stage on survival. Patients with stage I or 
II pancreatic ancer had a better prognosis than 
patients with stage Ill or IV. 
DNA ploidy correlates with the aggressiveness 
and prognosis of various types of neoplasms. In pan- 
creatic ancer, this correlation is less clear. The tumor 
ploidy was correlated with the survival times by some 
(10-13,21,22). but not by all authors (14,15). The 
survival time of the patients with a euploid DNA 
content in our study was not higher compared with 
Intermttional Jm~rual ~[ Pancreamh~gv Volume 26, /999 
82 Loertzer et al. 
that of the remaining 77% with an aneuploid DNA 
content. The discrepant results between studies may 
be explained by the reasons cited above, including 
technical problems associated with DNA flow cytom- 
etry. In contrast o many of the previously cited series 
using DNA flow cytometry, we applied static scan- 
ning DNA cytophotometry to utilize the possible 
benefit from the undisputed advantages of this 
method. These include the presence of an internal 
reference standard, the use of smaller tissue sam- 
ples, the ability to distinguish neoplastic ells from 
nonncoplastic ells visually and the ability to gen- 
erate histograms uncontaminated by debris and 
clumps of nuclei (23,24). 
DNA histogram classification according to Auer 
et al. did not show prognostic significance in our 
study. Furthennore, we were unable to find a sig- 
nificant correlation between the DNA content of neo- 
plastic cells and the conventional grading or MIB-I 
proliferating indices (13,14,25). 
One may conclude that the impact of proliferat- 
ing index and DNA ploidy for an individual patient 
on survival is usually quite small. This does not 
exclude, however, that these parameters may be 
useful in some specific subgroups of patients (i.e., 
patients with an early tumor stage). More studies are 
nccessary to define further potential subgroups of 
cancer patients for whom these cytological para- 
meters may be useful. 
In summary, MIB-I proliferating index and DNA 
ploidy are relevant cytological markers that can help 
to discriminate between chronic pancreatilis and pan- 
creatic cancer. The prognostic relevance of these 
cytological markers in pancreatic cancer patients, 
however, seems to be less relevant than tumor stage 
and of limited relevance for the individual cancer 
patient. 
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